Ganaxolone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ganaxolone. Educational only — not medical advice.
Labeled uses
ZTALMY is indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older.
Source: FDA labeling via NIH DailyMed (set d91612c4…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.